Functional, Ultrastructural, and Transcriptomic Changes in Rat Diaphragms with Different Durations of Cigarette Smoke Exposure

Overview

Journal Int J Chron Obstruct Pulmon Dis

Publisher Dove Medical Press

Specialty Pulmonary Medicine

Date 2020 Dec 10

PMID 33299306

Citations 3

Authors

Haiyan Sheng

Yijie Zhang

Xiaoqian Shi

Yuhan Hu

Baosen Pang

Jiawei Jin

Yingmin Ma

Affiliations

Soon will be listed here.

Abstract

Aims: The aim of the study was to explore the functional and structural changes of the diaphragm and underlying mechanisms in response to 12 or 24 weeks of cigarette smoke (CS) exposure in rats.

Materials And Methods: Rats were exposed to CS to develop a COPD model and the rats exposed to room air served as a control group. Rats were randomly divided into four groups: CS12W, CON12W, CS24W, and CON24W. Pulmonary function, lung histopathology, and the contractile properties and ultrastructure of diaphragm muscle were examined in these rats. The changes of transcriptomic profiling of diaphragm muscle were further compared between CS and control rats by the RNA Seq.

Results: Both CS groups showed lower FEV/FVC, elevated mean linear intercept (MLI), and reduced mean alveolar numbers (MAN) vs the control groups. The fatigue index (FI) of the diaphragm muscle from the CS12W group, but not CS24W, was significantly increased. Conversely, the force-frequency curves of the diaphragm muscle from the CS24W group, but not CS12W group, were significantly decreased. Consistently, mitochondrial number density (N) and volume density (Vv) were increased in the CS12W diaphragm muscle, while being decreased in the CS24W group. Furthermore, the diaphragm transcriptomic profiling results showed that genes regulating cell proliferation and energy metabolic activity were un-regulated and genes regulating protein degradation were down-regulated in the CS12W diaphragm, while CS24W diaphragm showed opposite changes.

Conclusion: These observations suggested a transition of diaphragm muscle from initial compensatory to decompensatory changes in function, structure, and gene expression during the development of COPD.

Citing Articles

Self-reported dyspnea and interest in a respiratory muscle training program among callers to the New York State Quitline.

Ray A, Carl E, Hyland A, Reid M, Mahoney M, Sheffer C Tob Induc Dis. 2025; 23.

PMID: 39882033 PMC: 11776376. DOI: 10.18332/tid/196755.

Exercise Attenuate Diaphragm Atrophy in COPD Mice via Inhibiting the RhoA/ROCK Signaling.

Li P, Wang Y, Cao Y, Shi J, Jiang M, Han X Int J Chron Obstruct Pulmon Dis. 2024; 19:1591-1601.

PMID: 39005647 PMC: 11244622. DOI: 10.2147/COPD.S460182.

Differences in Airway Remodeling and Emphysematous Lesions between Rats Exposed to Smoke from New-Type and Conventional Tobacco Varieties.

Wei K, Li Y, Du B, Wu J Antioxidants (Basel). 2024; 13(5).

PMID: 38790616 PMC: 11117731. DOI: 10.3390/antiox13050511.

Effect of Oxidative Stress on Diaphragm Dysfunction and Exercise Intervention in Chronic Obstructive Pulmonary Disease.

Zhang B, Li P, Li J, Liu X, Wu W Front Physiol. 2021; 12:684453.

PMID: 34163375 PMC: 8215263. DOI: 10.3389/fphys.2021.684453.

References

Ottenheijm C, Heunks L, Dekhuijzen R . Diaphragm adaptations in patients with COPD. Respir Res. 2008; 9:12. PMC: 2248576. DOI: 10.1186/1465-9921-9-12. View

Langen R, Gosker H, Remels A, Schols A . Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease. Int J Biochem Cell Biol. 2013; 45(10):2245-56. DOI: 10.1016/j.biocel.2013.06.015. View

van Hees H, Ottenheijm C, Ennen L, Linkels M, Dekhuijzen R, Heunks L . Proteasome inhibition improves diaphragm function in an animal model for COPD. Am J Physiol Lung Cell Mol Physiol. 2011; 301(1):L110-6. DOI: 10.1152/ajplung.00396.2010. View

Lewis P, OHalloran K . Diaphragm Muscle Adaptation to Sustained Hypoxia: Lessons from Animal Models with Relevance to High Altitude and Chronic Respiratory Diseases. Front Physiol. 2016; 7:623. PMC: 5149537. DOI: 10.3389/fphys.2016.00623. View

Vilaro J, Ramirez-Sarmiento A, Martinez-Llorens J, Mendoza T, Alvarez M, Sanchez-Cayado N . Global muscle dysfunction as a risk factor of readmission to hospital due to COPD exacerbations. Respir Med. 2010; 104(12):1896-902. DOI: 10.1016/j.rmed.2010.05.001. View

Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A . Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell. 2004; 117(3):399-412. PMC: 3619734. DOI: 10.1016/s0092-8674(04)00400-3. View

Greising S, Mantilla C, Gorman B, Ermilov L, Sieck G . Diaphragm muscle sarcopenia in aging mice. Exp Gerontol. 2013; 48(9):881-7. PMC: 3750110. DOI: 10.1016/j.exger.2013.06.001. View

Levine S, Bashir M, Clanton T, Powers S, Singhal S . COPD elicits remodeling of the diaphragm and vastus lateralis muscles in humans. J Appl Physiol (1985). 2012; 114(9):1235-45. PMC: 3656432. DOI: 10.1152/japplphysiol.01121.2012. View

Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M . KEGG for linking genomes to life and the environment. Nucleic Acids Res. 2007; 36(Database issue):D480-4. PMC: 2238879. DOI: 10.1093/nar/gkm882. View

10.

Gea J, Agusti A, Roca J . Pathophysiology of muscle dysfunction in COPD. J Appl Physiol (1985). 2013; 114(9):1222-34. DOI: 10.1152/japplphysiol.00981.2012. View

11.

Doucet M, Russell A, Leger B, Debigare R, Joanisse D, Caron M . Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007; 176(3):261-9. DOI: 10.1164/rccm.200605-704OC. View

12.

Zhang Y, Gao J, Luo Y . The effect of various durations of cigarette smoke exposure on muscle fibre remodeling in rat diaphragms. Biomed Pharmacother. 2019; 117:109053. DOI: 10.1016/j.biopha.2019.109053. View

13.

Doucet M, Debigare R, Joanisse D, Cote C, Leblanc P, Gregoire J . Adaptation of the diaphragm and the vastus lateralis in mild-to-moderate COPD. Eur Respir J. 2004; 24(6):971-9. DOI: 10.1183/09031936.04.00020204. View

14.

Souza R, Cardim A, Maia T, Rocha L, Bezerra S, Marinho P . Inspiratory muscle strength, diaphragmatic mobility, and body composition in chronic obstructive pulmonary disease. Physiother Res Int. 2019; 24(2):e1766. DOI: 10.1002/pri.1766. View

15.

Barreiro E, Gea J . Respiratory and Limb Muscle Dysfunction in COPD. COPD. 2014; 12(4):413-26. DOI: 10.3109/15412555.2014.974737. View

16.

Zhou X, Yi D, Wu Y, Pei X, Yu H, Chen Y . Expression of diaphragmatic myostatin and correlation with apoptosis in rats with chronic obstructive pulmonary disease. Exp Ther Med. 2018; 15(3):2295-2300. PMC: 5795556. DOI: 10.3892/etm.2018.5686. View

17.

Bolger A, Lohse M, Usadel B . Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014; 30(15):2114-20. PMC: 4103590. DOI: 10.1093/bioinformatics/btu170. View

18.

Testelmans D, Crul T, Maes K, Agten A, Crombach M, Decramer M . Atrophy and hypertrophy signalling in the diaphragm of patients with COPD. Eur Respir J. 2009; 35(3):549-56. DOI: 10.1183/09031936.00091108. View

19.

Hoppeler H, Mathieu O, Krauer R, Claassen H, Armstrong R, Weibel E . Design of the mammalian respiratory system. VI Distribution of mitochondria and capillaries in various muscles. Respir Physiol. 1981; 44(1):87-111. DOI: 10.1016/0034-5687(81)90078-5. View

20.

Levine S, Gregory C, Nguyen T, Shrager J, Kaiser L, Rubinstein N . Bioenergetic adaptation of individual human diaphragmatic myofibers to severe COPD. J Appl Physiol (1985). 2002; 92(3):1205-13. DOI: 10.1152/japplphysiol.00116.2001. View